You can also view this newsletter on View it on the web

Selleck offers over 400 Kinds of Active Pharmaceutical Ingredients (API) products in Cancer , Infection , Endocrinology , Metabolic Disease , Inflammation , Immunology , Cardiovascular Disease , and Neurological Disease area offered by Selleck! Featured Items
Bicalutamide(Casodex) Bicalutamide is an oral non-steroidal antiandrogen which can be used in the treatment of prostate cancer and hirsutism. read more >> Paclitaxel(Taxol) Paclitaxel is a microtubule polymer stabilizer with an IC50 of 0.1 PM for human enddothelial cells. read more >> Temsirolimus (Synonyms Torisel) Temsirolimus is a recently developed mTOR inhibitor with improved aqueous solubility. read more >> Rapamycin(Sirolimus) RAPA administration prevented the rejection of the donor graft, accelerated post-BMT hematopoietic recovery, and did not compromise the survival rate of a recipient. read more >>

Bortezomib(Synonms velcade) The dipeptide boronic acid inhibitor bortezomib can inhibit proteasome activity effectively (Ki-0.6 nM). read more >> Feedback about Bortezomib from Selleckchem buyers

Bortezomib purchased from Selleck Data from Carcinogenesis Vol.31 no.11 pp.1948-1955,2010

Bortezomib was purchased from Selleck Data from JVI Accepts, published online ahead of print on 12 January 2011

Additional Selleck API Products related to

Cancer Infection Endocrinology Immunology Inflammation Metabolic Disease Neurological Disease Cardiovascular Disease

Reviews
Schaedler,S,J.Krause,et al.(2010)."Hepatitis B virus induces expression of antioxidant response element-regulated genes by activation of Nrf2." J Biol Chem 285(52):41074-41086. more reviews>>

file:///C|/Users/Administrator/Desktop/20-03-2011.htm[2011/5/26 14:13:37]

Feedback
"I am very satisfied with your product and costumer service. Bortezomib works very well in our assay, it is comparably cheaper than other inhibitors that we tested is more reliable for our assays. We see a great effect by using 10nM concentration." ......Dr.Alexandra Segref, CECAD Cologne,Germany

Latest Reseach about

Everolimus for advanced pancreatic neuroendocrine tumors Yao,J.C.,M.H.Shah, et al.(2011).England. compared with placebo,Everolimus significantly prolonged progression-free survival among patients... read more>>

Pancreatic Tumors

Products are for research use only!

Follow us on: We do not sell or rent any part of information to third parties.

Selleck. Tel: +1-713-922-4115 +1-832-582-8158 2626 South Loop West, Suite 225, Houston, TX 77054 USA Fax: +1-713-796-9816 +1-832-582-8590

file:///C|/Users/Administrator/Desktop/20-03-2011.htm[2011/5/26 14:13:37]